Bivalent Booster Effectiveness Against New SARS-CoV-2 Variants Bivalent Booster Effectiveness Against New SARS-CoV-2 Variants

This study confirms that a bivalent mRNA booster dose provides additional protection against symptomatic XBB/XBB.1.5 infection for at least 3 months after vaccination.Morbidity & Mortality Weekly Report
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news